Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2003
10/07/2003CA2373821C Topical compositions for prostaglandin e1 delivery
10/07/2003CA2367096C Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions
10/07/2003CA2362508C Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
10/07/2003CA2241288C Pseudoephedrine hydrochloride extended release tablets
10/07/2003CA2212803C Redispersible nanoparticulate film matrices with protective overcoats
10/07/2003CA2207286C Localized delivery of factors enhancing survival of transplanted cells
10/07/2003CA2162854C Method for treating neurological disorders
10/07/2003CA2124821C Novel solid pharmaceutical dispersions
10/02/2003WO2003080848A1 Biobeads having foreign genetic substance immobilized to calcium alginate
10/02/2003WO2003080629A2 Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
10/02/2003WO2003080554A2 Iodinated triglyceride analogs
10/02/2003WO2003080183A1 Pharmaceutical combination of the cox-2 inhibitor etodolac and opioids
10/02/2003WO2003080181A2 Storage stable eplerenone formulation
10/02/2003WO2003080174A1 Medical treatment system and production method therefor
10/02/2003WO2003080123A1 Compositions for delivering biologically active drug and method of using the same
10/02/2003WO2003080120A1 Test system for evaluating the compatibility of biologically active substances with copolymers
10/02/2003WO2003080119A1 Responsive biomedical composites
10/02/2003WO2003080112A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003WO2003080109A1 Use of hydrogen peroxide producing enzyme for treatment of otitis media
10/02/2003WO2003080108A1 Stable pharmaceutical composition containing factor viii
10/02/2003WO2003080096A1 Compositions for treating and/or preventing pollenosis
10/02/2003WO2003080090A1 Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytochrome p-450
10/02/2003WO2003080086A1 A composition for treating gastric ulcer and a process for preparing the same
10/02/2003WO2003080079A1 Use of sulfoalkyl ether cyclodextrin as a preservative
10/02/2003WO2003080057A1 Downsized core tablet containing nifedipine
10/02/2003WO2003080056A2 Fine particle size pioglitazone
10/02/2003WO2003080043A1 Topical formulations of resorcinols and cannibinoids and methods of use
10/02/2003WO2003080040A1 Diclofenac sodium oral pharmaceutical
10/02/2003WO2003080035A1 Hybrid system for solubilizing pharmaceutically active substances in polymer matrices
10/02/2003WO2003080034A2 Method for the production and the use of microparticles and nanoparticles by constructive micronisation
10/02/2003WO2003080033A1 Microparticles
10/02/2003WO2003080032A2 Pharmaceutical formulation for the active ingredient budesonide
10/02/2003WO2003080031A1 Sustained release formulation of tramadol
10/02/2003WO2003080030A1 Stable tablets comprising pergolide mesylate
10/02/2003WO2003080029A1 No-donating nsaids adsorbed into carrier particles
10/02/2003WO2003080028A2 Method and apparatus for producing dry particles
10/02/2003WO2003080027A1 Nanoparticulate compositions of angiogenesis inhibitors
10/02/2003WO2003080026A1 Controlled release drug delivery system of pravastatin
10/02/2003WO2003080025A1 Topical composition based on ion-exchange resins, in particular for treating erythemas
10/02/2003WO2003080024A2 Nanoparticulate compositions of map kinase inhibitors
10/02/2003WO2003080023A2 Fast dissolving dosage forms having reduced friability
10/02/2003WO2003080022A2 Analgesics for nasal administration
10/02/2003WO2003080021A2 Formulation comprising buprenorphine
10/02/2003WO2003080020A1 Heat-reversible composition treating hyposalia and asialia
10/02/2003WO2003080019A1 Intravaginal reservoir drug delivery devices
10/02/2003WO2003080018A1 Intravaginal matrix drug delivery devices
10/02/2003WO2003079993A2 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION
10/02/2003WO2003079992A2 Pulmonary delivery for levodopa
10/02/2003WO2003079991A2 Method for administration of growth hormone via pulmonary delivery
10/02/2003WO2003079990A2 Microencapsulation using ultrasonic atomizers
10/02/2003WO2003079981A2 Bioadhesive drug delivery system
10/02/2003WO2003079976A2 A substance with sedative effect
10/02/2003WO2003079962A2 Assembled unit consisting of individually separable transdermal therapeutic systems
10/02/2003WO2003079958A1 System for orally administering active substances, vitamins and/or foodstuffs
10/02/2003WO2003079957A1 Administration form for oral administration of active ingredients, vitamins and/or nutrients
10/02/2003WO2003079945A1 Method of administering buprenorphine to treat depression
10/02/2003WO2003079923A1 Method of administering an injectable antibiotic to the ear of an animal
10/02/2003WO2003079885A2 Inhalable sustained therapeutic formulations
10/02/2003WO2003061629A3 Dna dosage forms
10/02/2003WO2003061379A3 Methods for inactivation of pathogens in biological materials
10/02/2003WO2003057862A3 Transdifferentiation of pancreatic acinar cells
10/02/2003WO2003028692A3 Acne treatment using oleanolic acid
10/02/2003WO2003017972A3 Multi-component polymeric systems with reverse thermal gelation behaviour (e.g. peo-ppo copolymers)
10/02/2003WO2002069944A3 Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists
10/02/2003WO2002066016A3 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine
10/02/2003WO2002056839A3 Pearlescent agent
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002005782A3 Stable salts of o-acetylsalicyclic with basic amino acids
10/02/2003WO2002000243A3 Stabilized interleukin 2
10/02/2003WO2002000191A9 Bdellosomes
10/02/2003WO2001005355A3 Formulations for il-11
10/02/2003US20030187525 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
10/02/2003US20030187423 Valved intradermal delivery device and method of intradermally delivering a substance to a patient
10/02/2003US20030187395 Intradermal delivery device
10/02/2003US20030187226 Process of high purity albumin production
10/02/2003US20030187167 Adjusting bulk density; compact tableting
10/02/2003US20030187122 Polymerization of vinyl acetate polymer in presenc eof free radical catalyst
10/02/2003US20030187115 Hydrogel adhesives for use on hair or fiber-populated surfaces
10/02/2003US20030187074 Oral compositions for treatment of diabetes
10/02/2003US20030187070 Ibuprofen solutions for capsule-filling and capsule preparations
10/02/2003US20030187069 Treatment of burns
10/02/2003US20030187062 Paclitaxel-based antitumor formulation
10/02/2003US20030187048 Topical applying to skin disorders; aqueous solution
10/02/2003US20030187036 Use of biguanide derivatives for making a medicine having a wound healing effect
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187019 Mixing drug with arginine; reduction of bitter taste
10/02/2003US20030186957 Methods of treatment and formulations of cephalosporin
10/02/2003US20030186956 Using inert gas; controlling humidity
10/02/2003US20030186952 Anticholesterol agents; cardiovascular disorders
10/02/2003US20030186951 Compositions and methods for enhancing corticosteroid delivery
10/02/2003US20030186938 Tablets for immediate oral administration; improved taste; antidepressants; for treatment of obsessive compulsive disorder and panic
10/02/2003US20030186935 Myeloglycan
10/02/2003US20030186933 Preparation of aqueous clear solution dosage forms with bile acids
10/02/2003US20030186931 Comprises trehalose; for treatment of Gougerot-Sjogren Syndrome
10/02/2003US20030186914 Precipitation occurs on substrate surfaces of oxides, nitrides, or carbides of metals and semiconductors, comprising use of water-soluble salts of compounds for treatment of these surfaces as sensor platforms, implants, medical devices
10/02/2003US20030186894 Dry powder compositions having improved dispersivity
10/02/2003US20030186893 Purified lh
10/02/2003US20030186870 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
10/02/2003US20030186849 Modified peptides and their use for the treatment of autoimmune diseases
10/02/2003US20030186843 Powder comprising active material and further comprising an indicator material that is capable of indicating to a patient that a dose of the active material has been administered
1 ... 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 ... 2991